Open label, multi-center, phase 1b/2 clinical trial to evaluate the safety and efficacy of autologous CAR-BCMA T cells (CT053) in subjects with relapsed and/or refractory multiple myeloma
NOT ENROLLING
Trial ID:
NCT03915184 Protocol # :
19-453
Phase
I/II
Disease Sites
Multiple Myeloma
Principal Investigator
Laubach, Jacob, Peter
Site Research Nurses
Coleman, Kimberly, C.
Dalton, Virginia, M.
Flaherty, Tina
Hogan, Sarah
Noonan, Kimberly Rogers
O'Brien, Alexandra
Regan, Eileen
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #19-453
19-453